Etopeak 90 Tablet contains Etoricoxib 90mg, a selective COX-2 inhibitor used primarily for the management of pain and inflammation associated with various musculoskeletal conditions. It is commonly prescribed for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis, providing effective relief from joint pain, swelling, and stiffness. Etoricoxib works by selectively blocking the cyclooxygenase-2 enzyme, which plays a key role in the inflammatory process, thereby reducing the production of prostaglandins responsible for pain and inflammation. Compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs), Etopeak 90 offers targeted action with potentially fewer gastrointestinal side effects, making it suitable for patients who require long-term anti-inflammatory therapy. The tablet should be taken orally, usually once daily, with or without food, as directed by a healthcare professional. It is important to use Etopeak 90 under medical supervision, especially in individuals with a history of cardiovascular disease, hypertension, kidney or liver impairment, as Etoricoxib may increase the risk of adverse effects in these populations. Common side effects may include headache, dizziness, and gastrointestinal discomfort. Patients should report any unusual symptoms or allergic reactions promptly to their physician.